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Abstract
Background:  Plasma membrane Ca2+-ATPases (PMCAs) are high affinity Ca2+ transporters
actively involved in intracellular Ca2+ homeostasis. Considering the critical role of Ca2+ signalling in
neuronal development and plasticity, we have analyzed PMCA-mediated Ca2+-ATPase activity and
PMCA-isoform content in membranes from mouse cortex, hippocampus and cerebellum during
postnatal development.
Results:  PMCA activity was detected from birth, with a faster evolution in cortex than in
hippocampus and cerebellum. Western blots revealed the presence of the four isoforms in all
regions, with similar increase in their expression patterns as those seen for the activity profile.
Immunohistochemistry assays in cortex and hippocampus showed co-expression of all isoforms in
the neuropil associated with synapses and in the plasma membrane of pyramidal cells soma, while
cerebellum showed a more isoform-specific distribution pattern in Purkinje cells.
Conclusion: These results show an upregulation of PMCA activity and PMCA isoforms expression
during brain development in mouse, with specific localizations mainly in cerebellum. Overall, our
findings support a close relationship between the ontogeny of PMCA isoforms and specific
requirements of Ca2+ during development of different brain areas.
Background
Nerve cells require highly complex mechanisms of Ca2+
regulation since a precise intracellular Ca2+ concentration
is needed for the appropriate development and function
of these cells. Plasma membrane Ca2+-ATPases (PMCAs)
are major components of this regulation. They hydrolyze
ATP in order to get the energy to transport Ca2+ from the
cytoplasm to the extracellular media across the plasma
membrane. The presence of four main isoforms (PMCA1-
4) encoded by four genes has been shown widely distrib-
uted in most eukaryotic cells [1,2]. Therefore, a strong
selective pressure has existed to keep all four isoforms
through evolution. Conserved domains among PMCA
isoforms correspond to essential transport functions,
whereas high diversity domains concern regulatory and
functional specialization of each isoform [3-5]. The asso-
ciation between tissue expression and specific cellular
functions seems to be the key of this diversity. During
neural development, the maintenance of resting cytosolic
Ca2+ at nM levels is critical for correct differentiation, den-
dritic growing and neural maturation [6], and PMCAs are
major players in this function. We have reported in a pre-
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vious study the specific distribution of PMCA isoforms
linked to specific cell types and maturation cell stages dur-
ing prenatal development in chick cerebellum [7]. How-
ever, the widespread use of mice as a reference laboratory
animal, which presents a mainly postnatal brain develop-
ment, motivated us to investigate the functional and spa-
tiotemporal expression patterns of these proteins in the
mouse brain. These aims contribute to fully understand
the Ca2+ metabolism in mouse brain during development.
Although the mRNA distribution of PMCA isoforms in
developing mouse has been reported by in situ hybridiza-
tion [8], a study at the protein level as well as at the func-
tional level in different areas of developing mouse brain
was still lacking. In this work, we have analyzed the
ATPase activity and isoforms expression of PMCA during
postnatal neural development in the mouse. These results
will contribute to a better understanding of the specific
role of these proteins in critical moments of Ca2+ homeos-
tasis during brain development.
Results
Functional profile of PMCA in different brain areas during 
development
The PMCA protein showed the capacity to catalyze ATP-
hydrolysis in a Ca2+-dependent manner from the first
stage in all areas (Fig. 1). Besides, the PMCA activity dur-
ing postnatal development followed two patterns, reach-
ing the Vmax at P8 in the cortex and at P15 stage in
hippocampus and cerebellum. Although the values of
Vmax were similar in all regions (0.237 ± 0.017 μmol·min-
1·mg-1) the increase of activity was more pronounced
(around 4-fold) in cortex and hippocampus than in cere-
bellum (around 2.3-fold).
Protein expression levels of PMCA isoforms in developing 
cortex, hippocampus and cerebellum
The expression of PMCA isoforms during development
was examined in the MV by Western blot using isoform-
specific antibodies (Fig. 2A). The anti-PMCA1 antibody
stained two protein bands whose expression progressively
increased with development until P15, in the three ana-
lyzed regions. The intensity of the lower band was higher
in cortex and hippocampus, while in cerebellum both var-
iants were similarly expressed. These bands seem to corre-
spond to PMCA1a (130 kDa) and PMCA1b (134 kDa)
variants, according to Filoteo et al. [9]. The PMCA2 anti-
body stained a spectrum of bands around 126-150 kDa in
the three regions, whose intensity progressively increased
with developmental stage. This was previously observed
in developing chick cerebellum [7]. The anti-PMCA3 anti-
body recognized three main variants whose expression
increased with development. The anti-PMCA4 reaction
was very strong in the three regions and increased during
development, detecting mainly a protein band that could
correspond to variant PMCA4b (133 kDa) and faintly the
variant 4a (128 kDa) in hippocampus and cerebellum,
according to Filoteo et al. [9]. Immunoreaction with β-
tubulin (a representative staining from each region is
shown) was used as protein loading control for quantifi-
cation (Fig. 2B). Overall, the largest increase in the expres-
sion of total PMCA appeared at P8 stage in cortex and at
PMCA activity in developing cortex, hippocampus and cere- bellum Figure 1
PMCA activity in developing cortex, hippocampus 
and cerebellum. Twenty μg of MV obtained from the indi-
cated brain regions at different developmental stages were 
used to measure PMCA activity, as described in the Experi-
mental Procedures. Data are the mean ± SE values obtained 
from three experiments performed in triplicate, and from 
two preparations.BMC Neuroscience 2009, 10:112 http://www.biomedcentral.com/1471-2202/10/112
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P15 in the other regions (Fig. 2C), being in good agree-
ment with the kinetic data.
Isoform-specific localization of PMCA pumps on sagittal 
sections of developing mouse brain
In order to address if changes in activity and expression
levels of PMCAs during development were associated with
the maturation of specific cell types, we analyzed their
localization in developing brain regions by immunohisto-
chemistry (Figs. 3, 4 &5). The observed distribution was
generally consistent with the temporal pattern given by
Western blotting. In cerebral cortex (Fig. 3), all PMCA iso-
forms were expressed in neural precursors at P0, but a
more restricted distribution was observed with cell differ-
entiation. The PMCA3 expression was comparatively
lower at all stages. At P30 stage, the four isoforms were
highly expressed in the neuropil and also in the plasma
membrane of the soma of pyramidal cells. The cytoplasm
of bodies and dendritic trunks were always PMCA-nega-
tive. In the hippocampal Ammon's horn (Fig. 4), the four
isoforms were weakly stained in poor-defined structures at
the earliest stages. At P8, cellular layers are already estab-
lished and PMCA1 and 2 were the highest expressed iso-
forms. They were located in the plasma membrane of the
soma of developing pyramidal neurons and showed an
intense punctuate staining throughout the neuropil of
stratum oriens and radiatus. At P30, all isoforms appeared
with similar expression levels and distribution. In contrast
to the other regions, the developing cerebellum revealed
clear differences of distribution among PMCA isoforms
(Fig. 5). Thus at P0, PMCA1 and 3 showed a lower expres-
sion in cerebellar neural precursors than PMCA2 and 4.
Immunodetection of PMCA isoforms in MV from different brain regions Figure 2
Immunodetection of PMCA isoforms in MV from different brain regions. A. MV (20 μg) from cortex, hippocampus 
and cerebellum at the indicated developmental stages were submitted to electrophoresis, blotted on PVDF membranes and 
incubated with specific anti-PMCA1, anti-PMCA2, anti-PMCA3 and anti-PMCA4 antibodies. Representative anti-β tubulin 
immunoreaction as loading control is also shown. B. Quantification of PMCA isoforms (combining all splice variants within each 
isoform) respect to β tubulin is represented. C. Total PMCA intensity in brain areas obtained from Fig. 2B by adding the band 
intensities of all isoforms in each stage of development.BMC Neuroscience 2009, 10:112 http://www.biomedcentral.com/1471-2202/10/112
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From P8 on, PMCA1 and 3 were observed as intense punc-
tuate staining in the neuropil within molecular layer.
PMCA2 was distributed in similar cellular regions as
PMCA1 and 3, being clearly located in the plasma mem-
brane of the soma and dendritic tree of Purkinje cells. By
contrast, PMCA4 at P30 stage was mostly detected in the
soma and primary dendritic trunk of Purkinje cells. In the
granular layer, mature granule cells were PMCA1- and
PMCA3-positives, while all isoforms seem to be expressed
in cerebellar synaptic glomeruli.
To analyze in detail if PMCA distribution in the neuropil
and cerebellar glomeruli corresponds with a synapse dis-
tribution, double immunohistochemistry assays were per-
formed in the three regions at P30, using anti-PMCA2 or
anti-PMCA3 antibodies (that differ in staining pattern in
various areas) as template and the synaptic marker synap-
tophysin (Fig. 6). A clear and specific co-localization of
PMCAs with synaptophysin was observed, thus confirm-
ing the presence of these pumps in synaptic areas.
Discussion
In this work we report the functional presence and immu-
nolocalization of PMCA isoforms during postnatal devel-
opment of mouse cortex, hippocampus and cerebellum,
three major regions implicated in processes of learning
and stereotype movements. The functional analysis of
PMCA activity revealed that these pumps are active from
birth and they are upregulated during brain development.
The PMCA activity was comparatively higher than the
activities of the two intracellular Ca2+ pumps, SPCA [10]
and SERCA (unpublished results) in developing mouse,
pointing up the high contribution of PMCAs to the ATP-
dependent Ca2+ transport throughout development. This
early necessity of Ca2+ regulation in neural precursors is in
good agreement with that found in chick cerebellum dur-
ing prenatal development [11], proving the importance of
Ca2+ signaling in early events of neural development. As in
chick, PMCA activity profile in mouse was closely related
with the time-dependence of isoform expression. We
observed in cerebral cortex a fast increase of PMCA activity
Localization of PMCA isoforms in parasagittal sections of  developing mouse cerebral cortex Figure 3
Localization of PMCA isoforms in parasagittal sec-
tions of developing mouse cerebral cortex. Images 
show the V layer of the cortex. PMCA1-4 isoforms were 
detected in developing pyramidal neurons (arrowheads) from 
the earliest stages to mature cells. PMCA2 was the highest 
isoform expressed and the PMCA3 the weakest in all ana-
lyzed stages. From P8, the four isoforms were located in the 
neuropil (asterisk) and in the plasma membrane of the bodies 
of cortical cells (arrowhead). Cytoplasm of the soma and 
dendritic trunks were immunonegatives. Scale bar: 50 μm.
Developmental distribution of PMCA isoforms in the CA1  area of hippocampal Ammon's horn Figure 4
Developmental distribution of PMCA isoforms in the 
CA1 area of hippocampal Ammon's horn. At P0, all 
isoforms were weakly expressed. Expression levels increase 
at P8 for PMCA1 and 2 and at P15 for PMCA3 and 4. At P30 
stage, all isoforms showed similar immunoreactions. They 
were located in the plasma membrane of the soma of devel-
oping pyramidal neurons (arrowhead) and in the neuropil 
(asterisk) of stratum oriens (so) and stratum radiatus (sr). Cyto-
plasm of cell bodies was PMCA-negative. pcl, pyramidal cell 
layer. Scale bar: 50 μm.BMC Neuroscience 2009, 10:112 http://www.biomedcentral.com/1471-2202/10/112
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during the first postnatal week, which is associated with a
similar temporal augment of PMCA1-4 isoform expres-
sion. However, in hippocampus and cerebellum a slow
increase in PMCA activity was observed, also related to a
later upregulation of PMCA isoforms expression. These
differences reflect special Ca2+ requirements during devel-
opment of different neural regions.
The increase of PMCA activity is accompanied by changes
in isoform-expression and distribution, in correlation
with functional cell maturation. In fact, the major increase
of PMCA activity mainly occurs during the period of great-
est synaptic development. The presence of different
PMCAs in the neuropil from early developmental stages
and the co-localization with the synaptophysin protein,
point us to the contribution of these Ca2+ pumps in the
formation and maturity of synapses. This synaptic distri-
bution of PMCAs has been also observed in developing
and adult rat [12-14], adult pig [15] and developing chick
[7,11], indicating that their localization is conserved
among species.
The expression of all PMCA isoforms was quite similar in
cortex and hippocampus, but differs from that in cerebel-
lum. Thus, the mouse cerebellar PMCA1 and 3 showed
the same distribution pattern as in adult rat [12], but dif-
fer from that found in developing chick [7] where they are
restricted to the soma and primary dendritic trunk of
Purkinje cells. The cerebellar PMCA2 was likewise local-
ized in different species [7,12], while PMCA4 showed
similar distribution to that observed for PMCA1 and 3 in
chick cerebellum [7]. Furthermore, the localization of
PMCA4 in developing mouse hippocampus differs from
that reported in developing rat, where it was confined to
the soma and dendrites of few scattered cells in CA1 [14].
The mentioned differences could be due to species-
dependent expression, or variation between pre- and post-
natal neural development. Besides, recent studies in rat
cerebellum report a postsynaptic localization for PMCA2
and a presynatic location for PMCA3 [16], which support
our results.
The precise targeting of each PMCA isoform (summarized
in Table 1) to definite cellular areas and their overlapping
localization in others, albeit at diverse expression levels,
can be explained by different roles of PMCA isoforms in
neural Ca2+ homeostasis. In fact, specific spatio-temporal
patterns of PMCA isoforms have been also reported in
other excitable tissues with different tasks, as developing
retina [17,18], and cochlea [19]. On the other hand,
PMCA isoforms differ in their kinetics and affinity for
Ca2+ and calmodulin [20], and are also differentially reg-
ulated by phosphorylation [20], proteolysis [21,22], or
acidic phospholipids [1]. Thus, the expression in a cell
type or subcellular region does not necessarily imply func-
tional redundancy, since diverse Ca2+ regulation exists in
different compartments of the cell during development.
Besides, other extrusion systems expressed in PMCA-posi-
tive areas as the Na+/Ca2+ exchanger [14], SERCA [11] or
SPCA [10], also show upregulation during development.
Moreover, each PMCA isoform may be integrated in mul-
tiprotein complexes that include PMCA-regulatory pro-
teins, and that are involved in specific and localized Ca2+
signals, e.g.: it has been described that PMCA2 and
PMCA4 can bind to Na+/H+ exchanger regulatory factor
[23] or proteins of the membrane-associated guanylate
kinase family [24], respectively. On the other hand, they
can be differentially integrated in membrane sub-
domains implicated in signal transduction [25,26]. The
Localization of PMCA isoforms in developing cerebellar cor- tex Figure 5
Localization of PMCA isoforms in developing cere-
bellar cortex. At P0, PMCA1 was weakly expressed in cer-
ebellar neural precursors, and from P8 it was located mainly 
in the neuropil of molecular layer (ml, asterisk). PMCA2 
showed high expression levels from P0, being associated to 
developing Purkinje cells, with a clear localization in the 
plasma membrane of soma (arrowhead) and dendritic tree 
(asterisk). PMCA3 showed similar distribution pattern than 
PMCA1 but with stronger immunoreaction. In contrast, 
PMCA4 was expressed in the soma of Purkinje cells (arrow-
heads) from P15, and also in main dendrites at P30 (large 
arrow). In the granular layer (gl) at P30 stage, while in mature 
granule cells only were found PMCA1 and 3 (open arrow-
head), all isoforms were expressed in cerebellar glomeruli 
(short arrow). Pcl, Purkinje cell layer. Scale bar: 50 μm.BMC Neuroscience 2009, 10:112 http://www.biomedcentral.com/1471-2202/10/112
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presence of PMCA isoforms in mouse cortex, hippocam-
pus and cerebellum, from the earliest post-natal stages,
and their differences in localization and content may well
be associated to isoform-dependent roles in Ca2+ signaling
during neural development. This is supported by studies
performed in PC12 neural-cell type, where suppression of
PMCA2 and 3 expression slowed neurite extension and
reduced cell survival [27]. Furthermore, recent observa-
tions of PMCA isoform-expression changes in breast can-
cer cell lines [28] and during cancer cell differentiation
[29] also support the importance of PMCAs in cell differ-
entiation.
Conclusion
The findings reported here show an upregulation of
PMCA activity and PMCA isoform expression during
brain development, related with a general coexpression of
isoforms in cortical and hippocampal regions and differ-
Double immunofluorescence of PMCA2 or PMCA3, and synaptophysin in different brain regions at P30 stage Figure 6
Double immunofluorescence of PMCA2 or PMCA3, and synaptophysin in different brain regions at P30 stage. 
Control slides without the primary antibody are shown to verify specificity of the fluorescence signals. PMCA2 and PMCA3 
(red) colocalized with synaptophysin (green) in the neuropil (asterisks) and in cerebellar glomeruli (short arrow), confirming 
the presence of these pumps in synaptic areas (merge). DAPI staining (blue) was used to visualize nuclei. so, stratum oriens; pcl, 
pyramidal cell layer; sr, stratum radiatus; ml; molecular layer, Pcl; Purkinje cell layer, gl; granular layer. Scale bar: 25 μm.
Table 1: Summary of the expression and relative abundance of PMCA1-4 isoforms in main neurons of cortex, hippocampus and 
cerebellum from developing mouse.
Cortex Hippocampus Cerebellum
P0 P8 P15 P30 P0 P8 P15 P30 P0 P8 P15 P30
PMCA1 Cell body (+) + + + (+) + ++ ++ (+) (+) + +
Neuropil (+) ++ ++ ++ (+) + ++ +++ (+) + ++ ++
PMCA2 Cell body (+) + ++ ++ (+) + ++ ++ + ++ +++ +++
Neuropil (+) ++ ++ +++ (+) + ++ ++ + ++ +++ +++
PMCA3 Cell body (+) (+) + + (+) (+) + ++ (+) (+) + +
Neuropil (+) + + ++ (+) + ++ +++ (+) ++ ++ ++
PMCA4 Cell body (+) (+) + + (+) (+) + + (+) (+) + ++
N e u r o p i l +++ + + + ( + ) ++ + +++ +
(+), weak; +, present; ++, strong; +++, very strong.BMC Neuroscience 2009, 10:112 http://www.biomedcentral.com/1471-2202/10/112
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ent localization in cerebellum. This study provides
insights into the specific implications of PMCA isoforms




Thapsigargin was from Sigma (Madrid, Spain) and
ammonium vanadate from Merck (Darmstadt, Germany).
The polyclonal anti-PMCA1, anti-PMCA2 and anti-
PMCA3 and the monoclonal anti-PMCA4 antibodies,
were from Affinity Bioreagents (Golden, CO, USA). The
sequences of their epitopes are described in Filoteo et al.
[9] for rat and human, and are also conserved in mouse.
The anti-β tubulin and anti-synaptophysin monoclonal
antibodies were from Sigma. The secondary antibodies
conjugated with peroxidase, those biotinylated and the
ExtrAvidin-peroxidase were obtained from Sigma, and the
fluorescent secondary antibodies labelled with Alexa488
or Alexa594 were from Molecular Probes (Eugene, OR,
USA). All other reagents were of the highest purity availa-
ble.
Preparation of membrane vesicles
Swiss mice at stages P0, P8, P15 and P30 (postnatal days
0-30) were used to prepare membrane vesicles (MV) from
cortex, hippocampus and cerebellum, following the pro-
tocol described in Sepúlveda et al. [30]. Animals were
manipulated according to the policies on the use of ani-
mals in research. Briefly, tissues were homogenized in 10
mM Hepes/KOH pH 7.4, 0.32 M sucrose, 0.5 mM MgSO4,
0.1 mM phenylmethylsulfonyl fluoride, 2 mM 2-mercap-
toethanol, and protease inhibitor cocktail (Roche Diag-
nostic, Mannheim, Germany). The homogenate was
centrifuged for 10 min at 1500 × g at 4°C. The pellet was
discarded and the supernatant was centrifuged for 45 min
at 100 000 × g at 4°C. The final pellet was resuspended in
10 mM Hepes/KOH pH 7.4, 0.32 M sucrose and stored at
-80°C until use. The protein content was evaluated by the
Bradford method [31].
Electrophoresis and Immunoblotting
Electrophoresis was performed in 6.5% (w/v) Laemmli
gels [32]. Proteins were electrotransferred to polyvinyli-
dene difluoride (PVDF) membranes using a Trans-Blot SD
semidry system (Bio-Rad). The PVDFs were blocked in a
Tris-buffer saline (TBS) containing 2% (w/v) of non-fat
dry milk (TBS-milk) for 30 min. After several washes in
TBS-Tween 0.05% (v/v), membranes were incubated over-
night at 4°C with the polyclonal antibodies anti-PMCA1,
anti-PMCA2 and anti-PMCA3 or the monoclonal anti-
bodies anti-PMCA4 (1:1000) and β-tubulin (1:1000).
Then, the PVDFs were washed extensively with TBS-milk
and incubated for 1 h at room temperature with anti-
mouse or anti-rabbit peroxidase-conjugated antibodies
(1:3000). The immunoreaction was visualized using 4-
methoxy-1-naphtol as substrate.
Ca2+-ATPase activity
The enzymatic activity was measured in MV by using a
coupled enzymatic assay at 37°C in specific conditions to
measure only the contribution of PMCA activity to total
(Ca2++Mg2+)-ATPase activity, as described in Sepulveda et
al. [30]. Briefly 20 μg of MV were incubated for 4 min with
a reaction mixture containing 50 mM Hepes/KOH pH 7.4,
100 mM, KCl, 100 μM CaCl2, 2 mM MgCl2, 5 mM NaN3,
100  μM 1,2-bis(2-minophenoxy)ethane-N, N, N', N'-
tetraacetic acid (3.16 μM free Ca2+), 0.22 mM NADH, 0.42
mM phosphoenolpyruvate, 10 IU of pyruvate kinase, 28
IU of lactate dehydrogenase and 0.01% saponin (1 mL
final volume). The reaction was started with 1 mM ATP
and subsequent activity measurements were done after
independent additions of 100 nM thapsigargin (to inhibit
the presence of SERCA activity), of 2 μM vanadate (to
selectively inhibit PMCA activity) and of 3 mM EGTA (to
measure Mg2+-ATPase activity). The SPCA activity was cal-
culated by subtracting the Mg2+-ATPase activity from the
activity in the presence of thapsigargin and vanadate. The
PMCA activity was calculated then by subtracting the
Mg2+-ATPase activity and the SPCA activity from the
ATPase activity in the presence of thapsigargin.
Tissue preparation for immunohistochemistry
Mice from stages P0, P8, P15 and P30 were anesthetized
with chloroform and subsequently the brains were fixed
by transcardiac perfusion with 4% (w/v) paraformalde-
hyde in phosphate buffered saline solution (PBS) and
post fixed by immersion in the same solution for 24 h at
4°C. Brains were rinsed in PBS, cryoprotected in 10% (w/
v) sucrose in PBS, and embedded in 10% (w/v) gelatin,
10% (w/v) sucrose in PBS. The blocks were frozen in iso-
pentane cooled at -70°C by dry ice, and stored at -80°C.
Serial parasagittal sections of 20 μm were collected on
Super-Frost Plus slides using a cryostat Leica CM1900.
Immunohistochemistry
Sections were permeabilized by immersion in PBS-0.05%
(v/v) Triton X-100 (PBS-T) for 15 min, and the endog-
enous peroxidase activity was quenched with PBS-0.5%
(v/v) H2O2 for 45 min. Sections were blocked in a solu-
tion containing 0.2% (w/v) gelatin, 0.25% (v/v) Triton X-
100 in PBS (PBS-G-T) and 0.1 M lysine for 1 h. Afterward,
sections were incubated in a humidified chamber over-
night at room temperature with the anti-PMCA1, anti-
PMCA2, anti-PMCA3 or anti-PMCA4 antibodies (1:50).
Subsequently sections were washed in PBS-T and incu-
bated with biotinylated goat anti-mouse or anti-rabbit
antibodies (1:200) and followed by ExtrAvidin-peroxi-
dase (1:200). The immunodetection was carried out with
0.03% (w/v) 3,3'-diaminobenzidine tetrahydrochlorideBMC Neuroscience 2009, 10:112 http://www.biomedcentral.com/1471-2202/10/112
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(DAB). The sections were dehydrated and mounted with
Eukitt for their observation under an Olympus CH20
microscope. Alternatively, double immunofluorescence
assays were performed with anti-PMCA2 or anti-PMCA3
combined with anti-synaptophysin (1:500), and using the
secondary antibodies Alexa594 goat anti-rabbit and
Alexa488 goat anti-mouse (1:750). Then, the sections
were incubated with 4',6-diamidino-2-phenylindole
(DAPI) to stain the nuclei, and covered with FluorSave
mounting medium. Results were visualized with an
Olympus IX81 fluorescence microscope. Negative con-
trols were performed for every set of experiments by omit-
ting the primary antibody.
Data analysis
Data were analyzed with SigmaPlot 10.0 software. Quan-
tification of signal intensity was done using Adobe Pho-
toshop 7.0.
Abbreviations
DAPI: 4',6-diamidino-2-phenylindole; PBS: phosphate
buffered saline; PMCA: plasma membrane Ca2+-ATPase;
PVDF: polyvinylidene difluoride; TBS: Tris buffered
saline.
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